Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 17/20 | 0.55 |
| ▸ | DDB1 | Q16531 | 15/20 | 0.55 |
| ▸ | IKZF3 | Q9UKT9 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | TNF | P01375 | 1/20 | 0.43 |
| ▸ | IL1B | P01584 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL410700 | 1.00 | CRBN (0.55) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL7284377 | 1.00 | CRBN (0.55) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL442296 | 1.00 | CRBN (0.55) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL20075961 | 0.84 | GAA (0.46) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL10074225 | 0.84 | DDB1 (0.61) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL11606116 | 0.83 | DDB1 (0.46) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL986701 | 0.83 | DDB1 (0.46) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL14601082 | 0.80 | DDB1 (0.44) | CRBNDDB1IKZF3ALDH1A1CHRM2 | |
| SCHEMBL14377303 | 0.79 | DDB1 (0.65) | CRBNDDB1IKZF3ALDH1A1CYP1A2 | |
| SCHEMBL15930060 | 0.79 | DDB1 (0.65) | CRBNDDB1IKZF3ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116769191-A | Preparation of amygdalin and application of amygdalin in health care products for enhancing immunity | 杨振东 | 2023-09-19 | — | — | CN | claimed |
| CN-110643670-A | Method for preparing D-glutamine by chemical enzyme method | 湖北新生源生物工程有限公司 | 2020-01-03 | — | — | CN | claimed |
| JP-55036453-A | — | — | None | — | — | JP | disclosed |
| EP-4730479-A2 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | Kyoto University (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4649963-A2 | IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | Arvinas Operations, Inc. (US) | 2025-11-19 | — | — | EP | disclosed |
| EP-3131588-B1 | IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-20250246685-A1 | FLAME-RETARDANT NON-AQUEOUS ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | KYOTO UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| WO-2025120994-A1 | SECONDARY BATTERY NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY PROVIDED WITH SAME | ステラケミファ株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025095088-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY, AND SECONDARY BATTERY PROVIDED WITH SAID SOLUTION | ステラケミファ株式会社 | 2025-05-08 | — | — | WO | disclosed |
| EP-4509184-A2 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR | Arvinas Operations, Inc. (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-2001041755-A2 | TOPICAL COMPOSITIONS COMPRISING THALIDOMIDE FOR THE TREATMENT OF INFLAMMATORY DISEASES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2001-06-14 | — | — | WO | disclosed |
| EP-1091726-A2 | ANALOGS OF 2-PHTHALIMIDINOGLUTARIC ACID AND THEIR USE AS INHIBITORS OF ANGIOGENESIS | EntreMed, Inc. (US) | 2001-04-18 | — | — | EP | disclosed |
| US-6161544-A | Methods for accelerated orthokeratology | KERATOFORM, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| EP-1051655-A1 | METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY | Ista Pharmaceuticals, Inc. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999058096-A9 | ANALOGS OF 2-PHTHALIMIDINOGLUTARIC ACID AND THEIR USE AS INHIBITORS OF ANGIOGENESIS | ENTREMED INC (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-1999058096-A2 | ANALOGS OF 2-PHTHALIMIDINOGLUTARIC ACID AND THEIR USE AS INHIBITORS OF ANGIOGENESIS | ENTREMED, INC. (US) | 1999-11-18 | — | — | WO | disclosed |
| WO-1999039238-A1 | METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY | KERATOFORM, INC. (US) | 1999-08-05 | — | — | WO | disclosed |
| JP-S5536453-A | NOVEL IMMUNOSUPPRESSIVE AGENT | MITSUBISHI CHEM IND LTD | 1980-03-14 | — | — | JP | disclosed |
| US-4087331-A | CATALYTICALLY REACTING THE ENZYME WITH A SYNTHETIC PEPTIDE OF GLUTAMIC ACID, DIAZOTIZING THE CLEAVAGE PRODUCT | COULTER ELECTRONICS, INC. (US) | 1978-05-02 | — | — | US | disclosed |